PS
PJP icon

Principal Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Principal Securities’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-140
Closed -$11.6K – 3837
2025
Q1 		$11.6K Hold
140
– – ﹤0.01% 2459
2024
Q4 		$11.6K Hold
140
– – ﹤0.01% 2455
2024
Q3 		$12.2K Buy
140
+1
+0.7% +$86 ﹤0.01% 2347
2024
Q2 		$11.5K Hold
139
– – ﹤0.01% 2326
2024
Q1 		$11.2K Sell
139
-270
-66% -$20.9K ﹤0.01% 2278
2023
Q4 		$31.1K Buy
+409
New +$29.2K ﹤0.01% 1700

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Principal Securities's PJP Position: Q2 2025 in Review

Principal Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2025, closing a stake of 140 shares — an estimated $11.6K sold.

Principal Securities first reported a position in PJP in Q4 2023 and held it in 6 quarters. The position peaked at $31.1K in Q4 2023. 92 funds tracked by Wall St. Rank hold PJP as of Q2 2025.

  • Principal Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
  • Principal Securities sold 140 Invesco Pharmaceuticals ETF shares in Q2 2025, an estimated $11.6K.
  • Principal Securities first reported a position in Invesco Pharmaceuticals ETF in Q4 2023 and held it in 6 quarters.
  • Principal Securities's Invesco Pharmaceuticals ETF position peaked at $31.1K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2025.

Based on Principal Securities's 13F filing for Q2 2025, filed 11 Aug 2025.